# The Effects of High Energy Acoustic Shock Wave Therapy on Local Skin Perfusion and DFUs

> **NCT03640988** · NA · TERMINATED · sponsor: **SANUWAVE, Inc.** · enrollment: 2 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DEVICE:** dermaPACE

## Key facts

- **NCT ID:** NCT03640988
- **Lead sponsor:** SANUWAVE, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-04-25
- **Primary completion:** 2021-01-03
- **Final completion:** 2021-01-03
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Mfr of product identified in protocol to measure perfusion after treatment with sponsor device withdrew support from the study. Sponsor decided to cancel the investigation due to lack of adequate replacement.
- **Last updated:** 2021-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03640988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03640988, "The Effects of High Energy Acoustic Shock Wave Therapy on Local Skin Perfusion and DFUs". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03640988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*